嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06998 嘉和生物-B

提前休市 12-24 12:08:22

3.050

-0.060

-1.93%

最高3.090	最低3.020	成交量12.35万
今开3.050	昨收3.110	日振幅2.25%
总市值16.10亿	流通市值16.10亿	总股本5.28亿
成交额37.83万	换手率0.02%	流通股本5.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"嘉和生物-B","latestPrice":3.05,"timestamp":1766549302796,"preClose":3.11,"halted":0,"volume":123500,"delay":0,"floatShares":528000000,"shares":528000000,"eps":-0.11088558389449621,"marketStatus":"提前休市","change":-0.06,"latestTime":"12-24 12:08:22","open":3.05,"high":3.09,"low":3.02,"amount":378270,"amplitude":0.022508,"askPrice":3.09,"askSize":500,"bidPrice":3.05,"bidSize":12500,"shortable":0,"etf":0,"ttmEps":0.06182876223542402,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":6,"adr":0,"listingDate":1602000000000,"exchange":"SEHK","adjPreClose":3.11,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0.516638,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"2593668934","title":"嘉和生物-B：12月31日起公司英文及中文股份简称不再印有“B”标记","url":"https://stock-news.laohu8.com/highlight/detail?id=2593668934","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593668934?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:40","pubTimestamp":1766392848,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B(06998)发布公告，根据上市规则第18A.12条向联交所提出申请后，联交所已授出批准上市规则第18A.09至18A.11条(相关规则)不适用于本公司，惟须待合并完成进行后方可作实。由于相关规则不适用并待合并完成于2025年12月30日(即通函所披露预期合并完成日期)进行后，自2025年12月31日(即紧随合并完成日期后的营业日(定义见上市规则))起，本公司的英文及中文股份简称不再印有“B”标记。本公司的股份代号维持不变，为“6998”。此外，本公司正进行建议更改公司名称后更改其股份简称，并将适时就有关新股份简称的生效日期另行刊发公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222164622a6c0aa17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222164622a6c0aa17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"1114621399","title":"嘉和生物药业（6998）特别股东大会通过合并及更名 多项决议正式获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1114621399","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114621399?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:36","pubTimestamp":1766392593,"startTime":"0","endTime":"0","summary":"嘉和生物药业（开曼）控股有限公司与标的公司的合并提案及多项相关议案，于2025年12月22日举行的股东特别大会上获得通过。会议审议并表决通过了包括清洗豁免、特别交易、增加法定股本以及一次性购股权计划在内的多项决议，为后续合并及业务发展铺路。嘉和生物药业指出，各项议案经股东高票通过后，将进一步落实与标的公司的合作事宜，有助于优化股权架构并提升公司的长远发展潜力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2593883554","title":"嘉和生物-B(06998)拟将法定股本增至6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593883554","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593883554?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:34","pubTimestamp":1766392447,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B 公布，由于股东已于股东特别大会上以投票表决方式通过批准建议更改公司名称的第6 项决议案，故于本公告日期，建议更改公司名称的条件已获达成。由于股东已于股东特别大会上以投票表决方式通过批准建议增加法定股本的第3 项决议案，公司法定股本已透过增设20亿股每股面值0.00002美元的股份，由2万美元增加至6万美元，该等股份在所有方面与公司现有股份享有同等地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","06998","BK1574"],"gpt_icon":0},{"id":"2593466831","title":"嘉和生物-B12月22日主力净流出51.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2593466831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593466831?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391322,"startTime":"0","endTime":"0","summary":"12月22日, 嘉和生物-B股价跌2.65%，报收3.31元，成交金额228.5万元，换手率0.13%，振幅7.65%，量比1.71。嘉和生物-B今日主力资金净流出51.1万元，上一交易日主力净流出0万元。该股近5个交易日下跌5.16%，主力资金累计净流出74.8万元；近20日主力资金累计净流出243.0万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161637a4697f63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161637a4697f63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06998","BK1583","BK1161"],"gpt_icon":0},{"id":"2592180192","title":"嘉和生物-B12月18日主力净流出23.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2592180192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592180192?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:15","pubTimestamp":1766045747,"startTime":"0","endTime":"0","summary":"12月18日, 嘉和生物-B股价跌3.42%，报收3.39元，成交金额128.6万元，换手率0.07%，振幅4.84%，量比0.79。嘉和生物-B今日主力资金净流出23.7万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.61%，主力资金累计净流出158.0万元；近20日主力资金累计净流出213.5万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218162041a6b1a212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218162041a6b1a212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2590504761","title":"嘉和生物-B12月12日主力净流出21.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590504761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590504761?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:15","pubTimestamp":1765527340,"startTime":"0","endTime":"0","summary":"12月12日, 嘉和生物-B股价跌0.83%，报收3.60元，成交金额106.8万元，换手率0.06%，振幅4.96%，量比0.45。嘉和生物-B今日主力资金净流出21.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.93%，主力资金累计净流出43.5万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出83.2万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121216245495397f6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121216245495397f6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","06998"],"gpt_icon":0},{"id":"2589337909","title":"嘉和生物-B(06998)：来罗西利(GB491)纳入国家医保药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337909","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589337909?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:39","pubTimestamp":1765193995,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B 发布公告，来罗西利已纳入由国家医疗保障局于2025年12月7日发布的《国家基本医疗保险、生育保险和工伤保险药品目录》。此乃来罗西利首次被纳入国家医保药品目录。本公司相信，来罗西利进入医保目录，不仅能够极大的提升患者的用药可及性，减轻其经济负担，亦有力加速来罗西利的商业化进程和市场渗透，进一步提振创新回报。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"嘉和生物-B(06998)：来罗西利(GB491)纳入国家医保药品目录","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK1161","06998"],"gpt_icon":0},{"id":"2589222238","title":"港股首宗18A反向并购，通过港交所聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2589222238","media":"张通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589222238?lang=zh_cn&edition=full","pubTime":"2025-12-06 18:03","pubTimestamp":1765015403,"startTime":"0","endTime":"0","summary":"张通社 zhangtongshe.com｜立足张江，面向上海，服务科创｜近日，据港交所文件，嘉和生物药业（开曼）控股有限公司通过港交所上市聆讯，距离完成并购上市仅一步之遥。亿腾医药拟通过换股方式反向收购嘉和生物，这是港股18A首例反向收购案。如今，这场港股18A首例反向收购交易迎来最新进展，以更新后的招股书材料向港交所进一步推进上市流程。亿腾医药此前曾四次递交H股发行上市申请，期间曾在2021年6月通过港交所聆讯，但彼时公司未启动招股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206181216a727753e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206181216a727753e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","LU1481107354.HKD","LU0955623706.USD","LU0577902371.SGD","LU0072462343.USD","06998","BK1583","LU0370786039.SGD","HKXCY","LU0648948544.HKD","LU0417516738.SGD","LU0096374516.USD","LU0197773160.USD","LU0211977185.USD","LU0651947912.USD","LU0762541174.USD","LU1734074674.USD","BK1574","LU1242518931.SGD","LU0348827113.USD","BK1131","HEXmain","LU0384037296.USD","00388","LU0594300179.USD","LU0791590937.USD","LU0197773673.USD","LU0762542818.HKD","LU0320764599.SGD","LU1282649141.HKD","LU0501845795.SGD","LU0572944931.SGD","LU0762540952.USD","LU0106959298.USD","BK1161","LU2257852520.SGD","SG9999002562.SGD","LU0856984785.SGD","LU0516423091.SGD","LU1044875133.USD","IE0003851619.USD","BK1610","LU0594300419.USD","LU0169518387.USD","LU0650527681.SGD","LU1981816686.USD","09939","LU0708995583.HKD","80388","BK1589"],"gpt_icon":0},{"id":"2589184136","title":"嘉和生物-B12月05日获主力加仓6.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589184136","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589184136?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922547,"startTime":"0","endTime":"0","summary":"12月05日, 嘉和生物-B股价涨4.46%，报收3.75元，成交金额373.6万元，换手率0.19%，振幅6.96%，量比1.93。嘉和生物-B今日主力资金净流入6.3万元，上一交易日主力净流入34.0万元。该股近5个交易日上涨8.67%，主力资金累计净流出11.9万元；近20日主力资金累计净流出470.8万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205162008a7257ef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205162008a7257ef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","06998"],"gpt_icon":0},{"id":"1183703103","title":"嘉和生物药业（开曼）（6998）发布合并及反向收购等多项交易公告 并将寄发相关通函","url":"https://stock-news.laohu8.com/highlight/detail?id=1183703103","media":"公告速递","labels":["corporation","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183703103?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:46","pubTimestamp":1764859564,"startTime":"0","endTime":"0","summary":"嘉和生物药业（开曼）控股有限公司于2025年12月5日发布公告，内容涉及拟进行的非常重大收购事项及关连交易、新上市申请的反向收购、清洗豁免申请及涉及股东人员留任计划等多项交易，并计划于同日向股东寄发相关通函。该公告显示，嘉和生物药业旗下合并附属公司与标的公司之间的合并协议包括根据特定授权发行代价股份、申请上市委员会批准进行反向收购及拟更改公司名称、拟增加公司法定股本，以及拟采纳一次性购股权计划等事宜。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2589322862","title":"嘉和生物-B12月04日主力净流入34.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2589322862","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589322862?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836129,"startTime":"0","endTime":"0","summary":"12月04日, 嘉和生物-B股价涨1.99%，报收3.59元，成交金额366.4万元，换手率0.19%，振幅3.98%，量比2.36。嘉和生物-B今日主力资金净流入34.0万元，上一交易日主力净流出30.8万元。该股近5个交易日上涨1.69%，主力资金累计净流出18.2万元；近20日主力资金累计净流出448.9万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161734952a71db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161734952a71db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"1182889947","title":"异动解读 | 嘉和生物-B盘中大涨5.11%，因通过港交所上市聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1182889947","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182889947?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:08","pubTimestamp":1764814107,"startTime":"0","endTime":"0","summary":"嘉和生物-B今日盘中大涨5.11%，表现显著强于大盘。消息面上，嘉和生物药业（开曼）控股有限公司已通过港交所上市聆讯，这意味着该公司在港交所的IPO进程取得重要进展。根据招股书，嘉和生物主要从事肿瘤及自体免疫药物的开发及商业化，产品管线覆盖乳腺癌、肺癌及胃肠道肿瘤等全球前三大肿瘤靶标。嘉和生物此次上市将依据《上市规则》第18A章，成为香港首宗未盈利生物科技公司反向并购案例。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"78017fe3ba4f859116cb01c02d313574","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06998"],"gpt_icon":0},{"id":"1149228687","title":"异动解读 | 嘉和生物-B盘中大涨5.11%，因通过港交所上市聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1149228687","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149228687?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:08","pubTimestamp":1764814106,"startTime":"0","endTime":"0","summary":"嘉和生物-B(06998)今日盘中大涨5.11%，表现强劲。消息面上，嘉和生物药业（开曼）控股有限公司已通过港交所上市聆讯。根据招股书，嘉和生物主要从事肿瘤及自体免疫药物的开发及商业化，产品管线覆盖乳腺癌、肺癌及胃肠道肿瘤等全球前三大肿瘤靶标。此次通过聆讯标志着公司向上市迈出了关键一步，增强了市场对其发展前景的信心。值得注意的是，嘉和生物此次上市是通过反向并购亿腾医药集团有限公司的方式完成，交易完成后公司将更名为“亿腾嘉和医药集团有限公司”。这将是香港首宗依据《上市规则》第18A章的未盈利生物科技公司反向并购案例，具有里程碑意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"78017fe3ba4f859116cb01c02d313574","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06998"],"gpt_icon":0},{"id":"1184350727","title":"港股生物医药股表现活跃！心玮医疗-B涨近5%，歌礼制药-B涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184350727","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184350727?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:43","pubTimestamp":1764812582,"startTime":"0","endTime":"0","summary":"12月4日，港股$生物(000504)$医药股盘初表现活跃，$心玮医疗-B(06609)$涨近5%，$歌礼制药-B(01672)$涨超4%，$嘉和生物-B(06998)$涨近3%，$康方生物(09926)$、$荣昌生物(09995)$涨超2%>>","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"78017fe3ba4f859116cb01c02d313574","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU0348827113.USD","LU2328871848.SGD","LU2488822045.USD","LU1961090484.USD","BK1587","LU0417516738.SGD","LU2476274720.SGD","IE00B543WZ88.USD","09939","BK1583","BK1191","01672","BK1100","LU1969619763.USD","06998","LU0348735423.USD","LU0561508036.HKD","LU0634319403.HKD","01477","BK1515","BK1161","LU1720050803.USD","LU0348784397.USD","LU0348825331.USD","09926","LU0348766576.USD","LU2778985437.USD","IE00BPRC5H50.USD","LU0417516571.SGD","LU1794554557.SGD","LU2476274308.USD","IE00B5MMRT66.SGD","LU0348767384.USD","09995","06609","LU0540923850.HKD","LU2399975544.HKD","BK1574","LU0348783233.USD"],"gpt_icon":0},{"id":"2588798230","title":"嘉和生物通过港交所上市聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2588798230","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588798230?lang=zh_cn&edition=full","pubTime":"2025-12-04 06:23","pubTimestamp":1764800590,"startTime":"0","endTime":"0","summary":"观点网讯：12月3日，嘉和生物药业通过港交所聆讯。据招股书，嘉和生物主要从事肿瘤及自体免疫药物的开发及商业化，产品管线覆盖乳腺癌、肺癌及胃肠道肿瘤等全球前三大肿瘤靶标。观点新媒体了解到，2025年11月，嘉和生物向港交所再次递交上市申请，亿腾医药集团有限公司拟通过换股方式反向收购嘉和生物。营业纪录期间，亿腾医药主要通过原研产品赚取收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204062824a7224490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204062824a7224490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"1123639304","title":"嘉和生物药业（06998）更新11月股份变动月报表，股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1123639304","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123639304?lang=zh_cn&edition=full","pubTime":"2025-12-03 15:12","pubTimestamp":1764745920,"startTime":"0","endTime":"0","summary":"嘉和生物药业（开曼）控股有限公司于2025年12月3日发布11月股份变动月报表。报告期为2025年11月，全月公司注册股本及已发行股份数量均无变化，股本保持稳定。公司注册股本的法定数目与面值未发生变动，仍为10亿股、每股面值USD 0.00002，对应注册股本总额USD 20,000。由于相关期权失效并未触发股份新增发行或回购，因此公司已发行股份总数继续维持稳定。公告显示，公司确认遵守香港联交所《上市规则》及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2588995770","title":"嘉和生物-B12月02日主力净流出21.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588995770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588995770?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663355,"startTime":"0","endTime":"0","summary":"12月02日, 嘉和生物-B股价跌1.77%，报收3.33元，成交金额104.2万元，换手率0.06%，振幅2.36%，量比0.83。嘉和生物-B今日主力资金净流出21.4万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.46%，主力资金累计净流出21.4万元；近20日主力资金累计净流出452.2万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202162142a4c79761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202162142a4c79761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2586336762","title":"嘉和生物-B盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586336762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586336762?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:55","pubTimestamp":1764122102,"startTime":"0","endTime":"0","summary":"2025年11月26日早盘09时55分，嘉和生物-B股票出现异动，股价大幅拉升5.23%。截至发稿，该股报3.420港元/股，成交量11万股，换手率0.02%，振幅2.77%。嘉和生物-B股票所在的生物技术行业中，整体涨幅为1.32%。其相关个股中，映恩生物-B、拨康视云-B、荣昌生物涨幅较大，振幅较大的相关个股有华康生物医学、映恩生物-B、荣昌生物，振幅分别为10.00%、9.20%、8.50%。嘉和生物-B公司简介：嘉和生物药业(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126095502a711c32f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126095502a711c32f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2585219449","title":"嘉和生物-B盘中异动 股价大跌5.00%报3.230港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585219449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585219449?lang=zh_cn&edition=full","pubTime":"2025-11-21 09:37","pubTimestamp":1763689048,"startTime":"0","endTime":"0","summary":"2025年11月21日早盘09时37分，嘉和生物-B股票出现波动，股价快速下挫5.00%。截至发稿，该股报3.230港元/股，成交量6.25万股，换手率0.01%，振幅6.47%。资金方面，该股资金流入1635港元，流出20.5735万港元。嘉和生物-B股票所在的生物技术行业中，整体跌幅为1.87%。今年4月15日，嘉和生物向港交所提交有关建议合并的新上市申请，该招股书目前为失效状态。2024年9月13日，嘉和生物与亿腾医药订立合并协议，亿腾医药拟通过换股方式反向收购嘉和生物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121093728a707c4d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121093728a707c4d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06998","BK1161","BK1574"],"gpt_icon":0},{"id":"2584197949","title":"反向收购后，这家上海药企再闯港交所！","url":"https://stock-news.laohu8.com/highlight/detail?id=2584197949","media":"新浪财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584197949?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:56","pubTimestamp":1763553383,"startTime":"0","endTime":"0","summary":"今年4月15日，嘉和生物向港交所提交有关建议合并的新上市申请，该招股书目前为失效状态。亿腾医药拟通过换股方式反向收购嘉和生物，这是港股18A首例反向收购案。今年上半年，亿腾医药收入同比有所下降。亿腾医药在招股书中称，因依赖少数主要客户而面临来自主要客户的集中度及交易对手风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111919593497735c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111919593497735c4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1515","BK1574","06998","09939"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0799},{"period":"1month","weight":-0.046},{"period":"3month","weight":-0.1985},{"period":"6month","weight":0.2101},{"period":"1year","weight":0.8187},{"period":"ytd","weight":0.7977}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"嘉和生物药业曼（开曼）控股有限公司是一家主要从事生物制药业务的公司。该公司的主营业务是从事人用生物制药产品的发现、研发及商业化。该公司产品管线包括来罗西利（GB491，Lerociclib）、GB261、GB263T等产品，涵盖乳腺癌、肺癌、胃肠道肿瘤以及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.050516},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004657},{"month":3,"riseRate":0.6,"avgChangeRate":0.024884},{"month":4,"riseRate":0.4,"avgChangeRate":-0.110106},{"month":5,"riseRate":0.6,"avgChangeRate":0.031188},{"month":6,"riseRate":0.6,"avgChangeRate":0.043248},{"month":7,"riseRate":0.4,"avgChangeRate":-0.090168},{"month":8,"riseRate":0.4,"avgChangeRate":0.095631},{"month":9,"riseRate":0.4,"avgChangeRate":-0.083466},{"month":10,"riseRate":0.4,"avgChangeRate":-0.052461},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.008673},{"month":12,"riseRate":0.666667,"avgChangeRate":0.050083}],"exchange":"SEHK","name":"嘉和生物-B","nameEN":"GENOR-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供嘉和生物-B(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"嘉和生物-B,06998,嘉和生物-B股票,嘉和生物-B股票老虎,嘉和生物-B股票老虎国际,嘉和生物-B行情,嘉和生物-B股票行情,嘉和生物-B股价,嘉和生物-B股市,嘉和生物-B股票价格,嘉和生物-B股票交易,嘉和生物-B股票购买,嘉和生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供嘉和生物-B(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}